NCT04361630View on ClinicalTrials.gov

Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

November 1, 2019

Study Completion Date

December 1, 2019

Conditions
Periodontitis
Interventions
DRUG

FGF 2

Following a standard surgical protocol, rhFGF-2 impregnated membranes will be placed in sites with gingival recession.

Trial Locations (1)

509002

SVS Institute of Dental Sciences, Mahabubnagar, Hyderabad

All Listed Sponsors
lead

SVS Institute of Dental Sciences

OTHER

NCT04361630 - Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects | Biotech Hunter | Biotech Hunter